Curing Cancer: Success!
Two months later, one man is completely cancer-free.
When I determined that ivermectin was curative for COVID, all the way back in April of 2020, I did so based on what was, at the time, relatively thin evidence. I had a pile of mechanistic research, a report from a hospital in South America that had begun to use it because they’d run out of hydroxychloroquine, a novel theory concerning the immunology at play, and a protocol, developed at length, with consideration of numerous microbiological and virological factors that ordinarily wouldn’t warrant so much as a second glance in that context.
Similarly, I find myself now in almost precisely the same position as regards this cancer protocol. I have a novel theory of immunology, a pile of mechanistic research, a protocol, and now, very limited, but nonetheless extant, evidence of use and success in vivo.
You can read the original article, detailing the mechanisms and the protocol, here.
Without further ado:
Case Report - Patient 1
The patient, a 60 year old male with a history of nodular basal cell carcinoma on the chest and melanoma on the ring finger, started the protocol approximately 4 weeks prior to reporting. The patient's diet was also modified to be mostly organic, low carb, and vegetable-centric, while monitoring systemic acid/base balance using urine pH strips. The patient also applied a 10% ivermectin and fenbendazole topical cream on the affected areas.
Progress:
Days 1-10: No notable changes.
Day 11: Inflammation and severe itching observed on the back of the hand and a 1x3 inch area above the basal cell. Oozing of clear amber liquid noted.
Day 15: The pink spot on the ring finger darkened, transformed into a bump, and the whole area became swollen and red.
Day 30+: The skin on the red oozing areas began sloughing off and was replaced by tender pink "baby skin." The chest basal cell shrank only slightly, and the hands and chest began healing.
Additional Treatments: The patient applied c-herb to the ring finger, resulting in a tiny hole where the dark spot/bump used to be. The chest basal cell was also treated next with c-herb. Timing of these additions is unclear.
Outcome: Both the chest lesion and the ring finger lesion disappeared, leaving craters in their places - the tumor on the chest wholly detached and fell off. The patient treated the craters with sangre de grado, and both areas have healed well: the skin on the back of the hand and chest area is now fully healed, with a healthy, normal appearance.
Takeaways
I am very surprised that two months later, despite a few people having indicated that they intended to begin using the protocol, I have only heard results from two people. The second report, which may have been confounded, and does not appear to have been as successful - but may contain useful lessons, nonetheless - follows further down the article, but let’s talk about this case first.
The man had a history of melanoma on the ring finger, which was thought to have been successfully excised quite some time ago. However, upon the 11th day of the protocol - the day at which the immune reaction is prompted by therapeutics to begin in earnest, after the first 10 days of preparation - and much to his surprise, the localized cytokine storms began not only near the chest tumor, but also on the hand. This indicates three things to me:
The preparation phase was successful.
The protocol starts out with high dose IVM and FBZ, followed by alternating days of ascorbic acid and sodium bicarbonate treatment, with lower dose FBZ. This phase is intended to cause metabolic stress to the tumor’s microenvironment, modifying the cytokine profile, destroying just a few cells, and giving the immune system a sample of the antigenic profile of the solid tumor mass, with which B and T cells can learn and develop the appropriate recognition and responses. This process is ordinarily inhibited by the inaccessibility of the tumor, due to the numerous and varied immune suppression functions they exhibit.
The “nuke it from orbit” strategy was successful.
And how! By giving the immune system sufficient time to learn to recognize the tumor antigens, and subsequently hitting the tumor with higher doses IVM and FBZ again, whilst ceasing the anti-inflammatory ascorbic acid that was used to soften it up via the Warburg effect, the therapeutic profile of the 11th day creates a perfect storm - a cytokine storm, at that - of immune response at the site of the tumor. This was precisely what I had theorized should happen; I couldn’t have imagined a more successful result in my dreams.
The protocol is not harmless - you must seek medical advice and supervision.